Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,628,804
  • Shares Outstanding, K 196,709
  • Annual Sales, $ 13,453 M
  • Annual Income, $ 4,431 M
  • 60-Month Beta 1.09
  • Price/Sales 3.32
  • Price/Cash Flow 7.15
  • Price/Book 3.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 6.87
  • Number of Estimates 24
  • High Estimate 7.45
  • Low Estimate 6.39
  • Prior Year 6.05
  • Growth Rate Est. (year over year) +13.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
216.49 +0.10%
on 03/22/19
336.57 -35.61%
on 03/04/19
-108.62 (-33.39%)
since 02/22/19
3-Month
216.49 +0.10%
on 03/22/19
344.00 -37.00%
on 01/23/19
-63.89 (-22.77%)
since 12/21/18
52-Week
216.49 +0.10%
on 03/22/19
388.67 -44.24%
on 07/25/18
-55.18 (-20.29%)
since 03/22/18

Most Recent Stories

More News
Downtrend Call Working As Biogen Inc Stock Falls 30.5% (BIIB)

SmarTrend identified a Downtrend for Biogen Inc (NASDAQ:BIIB) on February 7th, 2019 at $316.11. In approximately 1 month, Biogen Inc has returned 30.52% as of today's recent price of $219.64.

BIIB : 216.71 (-4.48%)
Biogen Stock Crashes on Termination of Alzheimer's Studies

Biogen (BIIB) and its Japanese partner, Eisai discontinue two late-stage studies evaluating aducanumab, in patients with Alzheimer's disease.

NVS : 93.42 (-0.26%)
RHHBY : 33.7600 (-1.06%)
SNY : 44.26 (-2.58%)
BIIB : 216.71 (-4.48%)
Company News For Mar 22, 2019

Companies in the news are: BIIB, CAG, DRI, WSM

WSM : 57.00 (-3.75%)
CAG : 26.45 (+2.44%)
DRI : 117.44 (+1.15%)
BIIB : 216.71 (-4.48%)
Biogen Inc (BIIB) Approaches New Downside Target of $220.59

Shares of Biogen Inc (NASDAQ:BIIB) opened today below their pivot of $228.36 and have already reached the first level of support at $223.71. Analysts will be watching for a cross of the next downside...

BIIB : 216.71 (-4.48%)
Financialbuzz.com: 'Market Recap' Week Ending March 22nd, 2019

U.S. stocks began the week strong as investors waited for the Federal Reserve's meeting to decide whether or not there will be another interest rate hikes this year. The Dow Jones Industrial Average gained...

FIS : 110.41 (+0.23%)
AAPL : 191.05 (-2.07%)
LVISF : 12.0000 (+6.19%)
MU : 41.62 (-5.39%)
WP : 110.39 (+0.10%)
FDX : 173.99 (-2.79%)
BIIB : 216.71 (-4.48%)
LEVI : 22.12 (-1.29%)
Biogen and Guess slide while Darden and Micron rise

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:

WSM : 57.00 (-3.75%)
DRI : 117.44 (+1.15%)
BIIB : 216.71 (-4.48%)
After Yesterday's Decline of 28.81%, Biogen Inc Offers Investors Better Value

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $227.15 to a high of $233.02. Yesterday, the shares fell 28.8%, which took the trading range below the 3-day low of $320.58...

BIIB : 216.71 (-4.48%)
Watch for Biogen Inc to Potentially Rebound After Falling 28.81% Yesterday

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $227.15 to a high of $233.02. Yesterday, the shares fell 28.8%, which took the trading range below the 3-day low of $320.58...

BIIB : 216.71 (-4.48%)
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer's Disease

ESALF : 55.0000 (+5.77%)
BIIB : 216.71 (-4.48%)
Jobless Claims Dip, Philly Fed Swings, Biogen (BIIB) Plummets

Jobless claims fell back to within the long-term range to 221K, Philly Fed surprised at 13.7 (after a negative February) and Biogen's phase 3 trial is halted.

QQQ : 178.56 (-2.20%)
DIA : 254.96 (-1.78%)
SPY : 279.25 (-1.92%)
BIIB : 216.71 (-4.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BIIB with:

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

2nd Resistance Point 230.31
1st Resistance Point 223.51
Last Price 216.71
1st Support Level 213.20
2nd Support Level 209.69

See More

52-Week High 388.67
Fibonacci 61.8% 322.90
Fibonacci 50% 302.58
Fibonacci 38.2% 282.26
Last Price 216.71
52-Week Low 216.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar